SCHEMBL29974695

SCHEMBL29974695

Nc1ccc(N)c(C(F)(F)F)c1-c1ccc(F)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.39
▸ SRC P12931 1/20 0.36
▸ BRAF P15056 1/20 0.36
▸ KDR P35968 1/20 0.36
▸ USP7 Q93009 1/20 0.36
▸ ALDH1A1 P00352 3/20 0.35
▸ ACHE P22303 1/20 0.35
▸ CYP1A2 P05177 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ ENPP1 P22413 1/20 0.34
▸ GYS1 P13807 1/20 0.34
▸ MAPK14 Q16539 3/20 0.33
▸ RPS6KB1 P23443 1/20 0.33
▸ FFAR4 Q5NUL3 1/20 0.33
▸ KIF11 P52732 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23579398 1.00 KDM4E (0.39) KDM4ESRCBRAFKDRUSP7
SCHEMBL1664825 0.86 KIF11 (0.48) KDM4EUSP7ALDH1A1ACHECYP3A4
SCHEMBL29974505 0.82 ALDH1A1 (0.40) KDM4EUSP7ALDH1A1ACHECYP1A2
SCHEMBL29620304 0.72 KIF11 (0.36) KDM4EUSP7ALDH1A1CYP3A4HPGD
SCHEMBL6313808 0.72 KIF11 (0.36) KDM4EUSP7ALDH1A1CYP3A4HPGD
SCHEMBL29974866 0.72 HSD11B1 (0.41) KDM4EALDH1A1GLAGAA
SCHEMBL29974481 0.72 TRPA1 (0.35) KDM4ESRCBRAFKDRALDH1A1
SCHEMBL30234670 0.72 CYP3A4 (0.43) KDM4ESRCBRAFKDRALDH1A1
SCHEMBL29013658 0.70 KIF11 (0.60) KIF11
SCHEMBL30972581 0.68 HSD17B10 (0.44) KDM4EUSP7ALDH1A1ACHECYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115135316-A Lipoxygenase inhibitors 思研(SRI)国际顾问与咨询公司 2022-09-30 — — CN disclosed
Send feedback